VERTEX PHARMACEUTICALS INC / MA Interest Payable, Current
VERTEX PHARMACEUTICALS INC / MA (VRTX) had Interest Payable, Current of $1.39 million as of 2016-12-31, per its 10-K filed 2017-02-23.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2017-02-23
- 2016-12-31: Interest Payable, Current $1.39M.
- 2015-12-31: Interest Payable, Current $4.64M.
- 2014-12-31: Interest Payable, Current $5.44M.
- 2013-12-31: Interest Payable, Current $0.00.
| Period end | Interest Payable, Current |
|---|---|
| 2016-12-31 | $1.39M 10-K · filed 2017-02-23 |
| 2015-12-31 | $4.64M 10-K · filed 2017-02-23 |
| 2014-12-31 | $5.44M 10-K · filed 2016-02-16 |
| 2013-12-31 | $0.00 10-K · filed 2015-02-13 |
| 2012-12-31 | $3.40M 10-K · filed 2014-02-11 |
| 2012-06-30 | $3.36M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $6.71M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $3.36M 10-K · filed 2013-03-01 |
| 2011-09-30 | $6.70M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $3.35M 10-Q · filed 2011-08-09 |
| 2011-03-31 | $6.81M 10-Q · filed 2011-05-06 |
| 2010-12-31 | $3.46M 10-K · filed 2012-02-22 |
| 2010-09-30 | $112.00K 10-Q · filed 2010-10-28 |
| 2009-12-31 | $571.00K 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |